Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP299499.RAkPsGp-Ril-bE9KSy-VFaIjoa__NAr69TpgyFwXrdD8Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP299499.RAkPsGp-Ril-bE9KSy-VFaIjoa__NAr69TpgyFwXrdD8Y130_assertion type Assertion NP299499.RAkPsGp-Ril-bE9KSy-VFaIjoa__NAr69TpgyFwXrdD8Y130_head.
- NP299499.RAkPsGp-Ril-bE9KSy-VFaIjoa__NAr69TpgyFwXrdD8Y130_assertion wasGeneratedBy ECO_0000203 NP299499.RAkPsGp-Ril-bE9KSy-VFaIjoa__NAr69TpgyFwXrdD8Y130_provenance.
- NP299499.RAkPsGp-Ril-bE9KSy-VFaIjoa__NAr69TpgyFwXrdD8Y130_assertion wasDerivedFrom befree-20140225 NP299499.RAkPsGp-Ril-bE9KSy-VFaIjoa__NAr69TpgyFwXrdD8Y130_provenance.
- NP299499.RAkPsGp-Ril-bE9KSy-VFaIjoa__NAr69TpgyFwXrdD8Y130_assertion SIO_000772 19924441 NP299499.RAkPsGp-Ril-bE9KSy-VFaIjoa__NAr69TpgyFwXrdD8Y130_provenance.
- NP299499.RAkPsGp-Ril-bE9KSy-VFaIjoa__NAr69TpgyFwXrdD8Y130_assertion evidence source_evidence_literature NP299499.RAkPsGp-Ril-bE9KSy-VFaIjoa__NAr69TpgyFwXrdD8Y130_provenance.
- NP299499.RAkPsGp-Ril-bE9KSy-VFaIjoa__NAr69TpgyFwXrdD8Y130_assertion description "[In the current pilot study, BC with p16 gene hypermethylation had a lower risk of recurrence after treatment with IL-2, as compared to IL-2 treated BC without p16 hypermethylation (p = 0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299499.RAkPsGp-Ril-bE9KSy-VFaIjoa__NAr69TpgyFwXrdD8Y130_provenance.